Navigation Links
Simvastatin Plus Niacin May Lower Heart Risks

Treatment combining the cholesterol drug simvastatin with the B vitamin niacin lowers the risk of heart attack and other artery-disease complications by up to 90% in some patients. The study of 160 adults with clogged heart arteries and low HDL (good) cholesterol showed that 3 years of the combo treatment improved HDL levels, caused artery blockages to recede and significantly lowered heart complications compared with an inactive placebo. //

Both lowering LDL, the "bad" cholesterol, and raising HDL help lower the risk of cardiac "events" such as heart attack. Brown, a researcher at the University of Washington in Seattle, and his colleagues reasoned that cutting LDL with a statin drug and raising HDL with niacin could potentially double the benefits for at-risk patients. And since low HDL may reflect an antioxidant deficiency, treatment with such vitamins could be expected to confer still more protection.

In the study, patients took either a combination of simvastatin (Zocor) and niacin alone, antioxidants alone, simvastatin-niacin plus antioxidants, or placebo. The antioxidant treatment included vitamins E, C, beta-carotene and selenium. Over 3 years, patients on simvastatin-niacin were 60% to 90% less likely than placebo patients to have a heart attack or stroke, need artery-clearing surgery or to die from causes related to their artery disease. These patients also showed a slight regression in their artery blockages, while on average all of the other groups showed worsening artery narrowing.

Patients on the combination plus antioxidants had more artery narrowing after 3 years and their HDL increases were not as strong compared with patients on simvastatin-niacin alone. Their risk of cardiac complications was lower, but not as low as that of patients on the combination alone. Treatment with antioxidants alone actually lowered an HDL component called HDL2 and did not cut patients' risk of heart attack and other complications.


'"/>




Related medicine news :

1. Ranbaxy Gets USFDA Nod For Simvastatin
2. Niacin Safe for Diabetics
3. Ritalin May Lower Cocaine Abuse
4. Eating More Often May Help Lower Cholesterol
5. Lower surgical volume linked to higher death rate
6. Lowering blood pressure beneficial for PAD patients
7. Lower chance of bone fracture with Vitamin D supplementation
8. Tea Pill Lowers Cholesterol
9. Aspirin Lowers Leukemia Risk
10. Almonds Help Lower Cholesterol
11. Lowering Risk of Breast Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating its ... location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. There ... TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, DDS, ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... Cosmetic dentistry is a fast-growing field as more patients are discovering the many different ... more about the options currently available to them and which ones might work for ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) -- Dr. ... Potter -- are proud of the recent release of their 2014 in vitro fertilization ... published the latest verified data for 375 U.S. member clinics. *Preliminary data shows ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology: